SLU-PP-332 Capsules Overview This research-grade small molecule is provided for laboratory and experimental use only. SLU-PP-332 is being tested in experimental models focusing on metabolic efficiency, mitochondrial activation, and signaling pathways that mimic exercise. Research focuses on how cells adapt to increased energy demands without physical stress. SLU-PP-332 capsules are widely recognized for their potential to enhance vitality and overall well-being. This formulation is designed to support mood, help protect against chronic conditions, and, according to emerging data, may help slow some aspects of aging. Scientific studies have repeatedly shown that the use of SLU-PP-332 capsules can: help prevent cardiovascular disease, support cognitive function, improve overall well-being. Traditionally, the benefits associated with exercise have been difficult to replicate using pharmacological compounds. With the introduction of SLU-PP-332 capsules, a new opportunity is emerging for researchers and individuals interested in the physiological benefits of exercise. SLU-PP-332 represents a significant advance in this field. It is an estrogen-related receptor (ERR) agonist, designed to selectively target the ERRα and ERRγ subtypes. In laboratory research, SLU-PP-332 has shown promising effects in: improving muscular endurance during exercise, assisting weight management, supporting cardiovascular performance, protecting the central nervous system during aging. Because it activates metabolic pathways similar to those induced by exercise, SLU-PP-332 has attracted considerable interest from the scientific community, especially among researchers studying longevity, energy metabolism, and human performance optimization. Product Description – SLU-PP-332 Capsules Synonyms: 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide Molar Mass: 290.32 g/mol CAS Number: 303760-60-3 PubChem ID: 5338394 Total Active Ingredient: 12,000 mg per container (200 mg per capsule) Shelf Life: 36 months







Reviews
There are no reviews yet.